Genmont Biotech Stock Net Income

Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Based on the recorded statements, GenMont Biotech reported net income of 113.13 M. This is 66.85% lower than that of the Pharmaceuticals sector and 61.51% higher than that of the Health Care industry. The net income for all Taiwan stocks is 80.19% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze GenMont Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GenMont Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GenMont Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.